A 30-million-person study compared cardiac risk.

The US TriNetX cohort found infection carried 4- to 5-fold higher myocarditis and mortality risk than BNT162b2 vaccination across four years.

Researchers report completing the two-dose series cut mortality 77% and myocarditis 62% versus a single shot.

Sources: Nature